TITLE

Age and the treatment of lung cancer

AUTHOR(S)
Brown, J S; Eraut, D; Trask, C; Davison, A G
PUB. DATE
June 1996
SOURCE
Thorax;Jun1996, Vol. 51 Issue 6, p564
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66106693

 

Related Articles

  • Lung cancer. Holdstock, Ruth // Practice Nurse;11/5/2010, Vol. 40 Issue 8, p17 

    The article offers information on treatment and management of lung cancer and examines how to best support patients who are undergoing treatment for this disease. Lung cancer is considered to be the second most common cancer in Great Britain. The two main types of primary lung cancer include...

  • Age, comorbidity, treatment decision and prognosis in lung cancer. Gullón Blanco, José Antonio; Suárez Toste, Isabel; Fernández Alvarez, Ramón; Rubinos Cuadrado, Gemma; Medina Gonzalvez, Agustín; González Martín, Isidro Jesús // Age & Ageing;Nov2008, Vol. 37 Issue 6, p715 

    A letter to the editor is presented about comorbidity, age, treatment decision and prognosis in lung cancer.

  • Miscellaneous.  // Current Medical Literature: Lung Cancer;2011, Vol. 5 Issue 1, p35 

    The article discusses research on lung cancer cases in England and Wales based on clinical data gathered from the National Lung Cancer Audit Database (LUCADA), published in a 2011 issue of "Lung Cancer" journal. It aims to examine demographic information, survival rates and treatments received...

  • Bevacizumab/carboplatin/paclitaxel.  // Reactions Weekly;Mar2014, Vol. 1493 Issue 1, p13 

    The article presents case studies of four men aged 69-71 years who developed toxicities during treatment with carboplatin, paclitaxel and bevacizumab for interstitial lung diseases with non-small cell lung cancer.

  • Treating lung cancer in the NHS market. Pickles, Hilary // BMJ: British Medical Journal (International Edition);12/06/97, Vol. 315 Issue 7121, p1548 

    Focuses on the improvement of the treatment of lung cancer in Great Britain. Improvements needed by lung cancer patient; Prevention as the main interest of health authorities in lung cancer.

  • Waging War On Lung Cancer. Brown, Ellen // FDA Consumer;May/Jun99, Vol. 33 Issue 3, p7 

    Focuses on lung cancer. Survival and detection; Diagnostic tests; Treatment; Future of lung cancer research; Findings, studies and developments related to lung cancer.

  • A Critical Look at Lung Cancer. Petty, Thomas L.; Rollins, Donald R. // Cortlandt Forum;03/25/2001, Vol. 14 Issue 3, p35 

    Focuses on technological methods for identification and treatment of lung cancer. Symptoms of lung cancer; Causes of lung cancer; People who have higher chances of getting lung cancer; Importance of early diagnosis in arresting the condition.

  • Lung Cancer: Perspectives and Prospects.  // Annals of Internal Medicine;Dec70, Vol. 73 Issue 6, p1003 

    Presents information on lung cancer. Improvements in the diagnosis of lung cancer; Scientific defects in the staging of lung cancer; Survival rate of a person with the disease; Adjuvant therapy in surgical treatment of lung cancer.

  • Smoking, treatment for Hodgkin's Disease, and subsequent lung cancer risk. Boivin, Jean-Francois // JNCI: Journal of the National Cancer Institute;10/18/95, Vol. 87 Issue 20, p1502 

    Editorial. Studies the effect of treatment of Hodgkin's disease and of smoking on subsequent lung cancer risk. Factors that increase lung cancer risk.

  • Adjuvant Chemotherapy with Cisplatin for Lung Cancer. Zepf, Bill // American Family Physician;9/1/2004, Vol. 70 Issue 5, p978 

    Deals with the use of adjuvant chemotherapy with cisplatin for lung cancer. Standard of care in the treatment of non-small-cell lung cancer.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics